5 Stocks to Buy Under $15 According to Travis Cocke’s Voss Capital

In this article, we discuss the 5 stocks to buy under $15 according to Travis Cocke’s Voss Capital. If you want to read our detailed analysis of Travis Cocke’s history, investment philosophy, and hedge fund performance, go directly to the 10 Stocks to Buy Under $15 According to Travis Cocke’s Voss Capital.

5. Immersion Corporation (NASDAQ:IMMR)

Voss Capital Stake Value: $3.9 million

 

Percent of Voss Capital’ Portfolio: 1.64%

 

Stock Price: $6.8

 

Number of Hedge Fund Holders: 21

Immersion Corporation (NASDAQ:IMMR) is based in California and operates as a tech company by developing and licensing haptic technology. This technology is used in various appliances like mobiles, medical training equipment, and consoles.

With 2.22 million shares, valued at $19.488 million, Raging Capital Management is the leading hedge fund investor in Immersion Corporation (NASDAQ:IMMR), as of the second quarter of 2021.

According to the database of Insider Monkey tracking 873 hedge funds in Q2 2021, 21 have stakes in Immersion Corporation (NASDAQ:IMMR), worth $68.6 million. This number has increased from 20 in the Q1 of 2021, worth $71.4 million.

4. 1847 Goedeker Inc. (NYSE:GOED)

Voss Capital Stake Value: $128.88 million

Percent of Voss Capital’ Portfolio: 1.42%

 

Stock Price: $3.15

 

Number of Hedge Fund Holders: 17

1847 Goedeker Inc. (NYSE:GOED), a Missouri-based company, operates an online store for selling furniture and appliances in the US. The company also provides appliance installation and removal services.

As of the second quarter of 2021, Voss Capital holds 888,800 shares of the company, worth $3.422 million. 1847 Goedeker Inc. (NYSE:GOED) represents 1.42% of Travis Cocke’s Voss Capital portfolio of 13F securities.

3. LiveXLive Media, Inc. (NASDAQ:LIVX)

Voss Capital Stake Value: $1.2 million

Percent of Voss Capital’ Portfolio: 0.51%

 

Stock Price: $2.86

 

Number of Hedge Fund Holders: 12

LiveXLive Media, Inc. (NASDAQ:LIVX) is based in Los Angeles and operates as a digital media company. The company concentrates on the acquisition and distribution of live music and podcasts.

As of the second quarter of 2021, Voss Capital holds 260,000 shares of the company worth $1.227 million.

According to the database of Insider Monkey tracking 873 hedge funds in Q2 2021, 12 have stakes in LiveXLive Media, Inc. (NASDAQ:LIVX), worth $23.2 million. This number has increased from 9 in the Q1 of 2021, worth $15.5 million.

2. Synchronoss Technologies, Inc. (NASDAQ:SNCR)

Voss Capital Stake Value: $1.2 million

Percent of Voss Capital’ Portfolio: 0.48%

 

Stock Price: $2.29

 

Number of Hedge Fund Holders: 22

Synchronoss Technologies, Inc. (NASDAQ:SNCR) is based in New Jersey and operates as a software company. The company develops software for network management and messaging. The company has worldwide operations.

As of the second quarter of 2021, Voss Capital holds 325,000 shares in Synchronoss Technologies, Inc. (NASDAQ:SNCR), valued at $1.167 million. These shares account for 0.48% of the 13F holdings of Voss Capital.

1. Aptose Biosciences Inc. (NASDAQ:APTO)

Voss Capital Stake Value: $1.4 million

Percent of Voss Capital’ Portfolio: 0.58%

 

Stock Price: $2.18

Number of Hedge Fund Holders: 38

Aptose Biosciences Inc. (NASDAQ:APTO) focuses on designing and developing personalized therapies for the oncology sector. The company also produces biotech solutions for genetic diseases. The company is based in Toronto.

At the end of the second quarter of 2021, Voss Capital held 420,161 shares worth $1.395 million in Aptose Biosciences Inc. (NASDAQ:APTO). The fund reduced its holdings by 5% in the second quarter of 2021. These shares account for 0.58% of the hedge fund’s 13F holdings.

OrbiMed Advisors is the leading hedge fund investor in Aptose Biosciences Inc. (NASDAQ:APTO), holding over 8 million shares worth $26.6 million as of the second quarter of 2021.

According to the database of Insider Monkey tracking 873 hedge funds in Q2 2021, 18 funds have stakes in Aptose Biosciences Inc. (NASDAQ:APTO), worth $93.5 million. This number has decreased from 23 in the Q1 of 2021, worth $173 million.

You can also take a peek at 10 Reddit’s WallStreetBets Stocks Under $5 and 10 Best Safe Dividend Stocks According to Billionaire Dan Loeb.

Follow Insider Monkey on Twitter